The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ARK ETF TRUST | INNOVATION ETF | 00214Q104 | 4,292 | 100 | SH | SOLE | 100 | 0 | 0 | |||
CRISPR THERAPEUTICS AG | COMMON STOCK | H17182108 | 4,842 | 100 | SH | SOLE | 100 | 0 | 0 | |||
INVESCO QQQ TR | UNIT SERIES 1 | 46090E103 | 3,333 | 9 | SH | SOLE | 9 | 0 | 0 | |||
ISHARES INC | CORE SP 500 ETF | 464287200 | 4,504 | 10 | SH | SOLE | 10 | 0 | 0 | |||
TESLA INC | COMMON STOCK | 88160R101 | 2,398 | 10 | SH | SOLE | 10 | 0 | 0 |